Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Sweden
/
Healthcare
Create a narrative
Medicover Community
OM:MCOV B Community
1
Narratives
written by author
0
Comments
on narratives written by author
7
Fair Values set
on narratives written by author
Create a narrative
Medicover
Popular
Undervalued
Overvalued
Community Investing Ideas
Medicover
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Acquisitions In Romania And Turkey Will Create New Opportunities
Key Takeaways Strategic acquisitions and expansions position Medicover for significant growth in margins and profitability across multiple regions. Operational leverage and strong performance in diagnostics support ongoing revenue growth and enhanced earnings in core markets.
View narrative
SEK 220.21
FV
9.9% overvalued
intrinsic discount
12.64%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
4 days ago
author updated this narrative
Your Valuation for
MCOV B
MCOV B
Medicover
Your Fair Value
SEK
Current Price
SEK 242.00
3.5% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
4b
2015
2018
2021
2024
2025
2027
2030
Revenue €3.7b
Earnings €52.6m
Advanced
Set Fair Value